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Abstract 
 
Objectives: Factors maintaining cognitive health are still largely unknown. In particular, the 
cognitive benefits associated with vitamin intake and vitamin supplementation are disputed.  
We investigated self-reported vitamin intake and serum vitamin levels with performance in 
cognitive factors sensitive to dementia progression in two large middle-aged general 
population cohorts.  
 
Methods: Survey data was used to assess regular vitamin intake in 4400 NCDS 1958 and 
1177 TwinsUK cohort members, and serum homocysteine and B vitamin levels were 
measured in 675 individuals from the TwinsUK study. Principal component analysis was 
applied to cognitive test performance from both cohorts resulting in two dementia-sensitive 
cognitive factors reflecting visuospatial associative memory and verbal semantic memory.  
 
Results: In both cohorts, individuals who reported regular intake of vitamins, particularly B 
vitamins, showed significantly better performance in visuospatial associative memory and 
verbal semantic memory (p < 0.001).  A significant association was also found between 
homocysteine levels, vitamin serum concentration and visuospatial associative memory 
performance which indicated that individuals with high B vitamin and homocysteine levels 
showed better visuospatial associative memory performance than individuals with low 
vitamin B levels (p < 0.05). 
 
Discussion: The findings demonstrate that early dementia-sensitive cognitive changes can be 
identified in middle-aged asymptomatic individuals and that regular vitamin intake is 
associated with improved cognitive performance. These findings reinforce the potential 
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cognitive benefits of regular vitamin intake, which should be considered as an economically 
viable therapeutic strategy for maintaining cognitive health.  
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Introduction 
 
The burden of dementia on the medical profession and on society as a whole has led to 
increased research efforts aimed at understanding the earlier stages of cognitive disease. It is 
now widely accepted that disease pathology may occur decades before clinical symptoms and 
a diagnosis of dementia. Mild cognitive impairment (MCI), which commonly presents in late 
middle-age (>60 years), is argued as a prodrome stage of Alzheimer’s disease (AD) as both 
MCI and AD present with particular deficits to mnemonic domains (1). However, individuals 
who develop MCI can remain in a stable clinical phenotype without developing AD or other 
neurodegenerative disorders whilst some individuals even improve back to a pre-impairment  
level of memory performance (2). Identifying factors that underlie protection against the 
onset of cognitive decline in middle-age is of great promise to medical science.  
 
Cognitive reserve describes resilience to cognitive decline either due to increased biophysical 
tolerance to pathology within the brain or improved mental adaptation to cognitive 
processing.  Many neurobiological, genetic, and environmental factors could contribute to 
cognitive reserve, including lifestyle factors such as exercise and diet (3, 4). The influence of 
diet is often studied by assessing the effect of vitamin supplements in randomised controlled 
trials, or through association with self-reported vitamin consumption in longitudinal cohorts. 
Whilst the relationship between cognitive function and clinical trial vitamin supplementation 
appears inconclusive, self-reported vitamin intake and measurements of vitamin levels have 
been associated with favourable cognitive outcomes.  
 
Numerous dietary supplements have been assessed in both healthy and at-risk groups but no 
clear consensus has emerged about the specific effects of vitamin supplementation or intake 
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on brain function and cognitive performance. The most popular candidates for vitamin 
studies have been B vitamins, most commonly combinations of vitamin B6, vitamin B12, and 
folate. Clinical studies investigating B vitamin supplements in individuals with MCI have 
consistently reported reductions in levels of homocysteine (Hcy) (a substance associated with 
risk for dementia and cognitive impairment), as well as improved cognitive performance and 
reduced rate of brain atrophy (5).  In contrast, B vitamin supplementation has been largely 
ineffective in studies of AD, as exemplified by a large clinical trial which demonstrated 
significantly reduced Hcy levels in AD patients but no slowing of cognitive decline (6). 
Research examining the effect of vitamin supplementation on cognitive performance in 
healthy control individuals has also produced incongruous results. For example, B vitamin 
supplementation studies in healthy controls have reported results ranging from no influence 
on cognitive performance (7) to beneficial effects for multiple cognitive domains (8). 
However, in contrast to B vitamin supplements, assessment of B vitamin serum levels and 
self-reported vitamin intake has been much more consistent in reporting positive links with 
cognitive performance (9-11).  
 
A number of studies which have examined other nutritional supplementation targets such as 
vitamin D and polyunsaturated fatty acids (PUFAs), also show discrepancy between vitamin 
supplementation and studies of self-reported vitamin intake or biochemical measurement of 
vitamin levels. For instance, low vitamin D levels have been linked with increased risk of 
cognitive impairment (12).  However, the supplementation of vitamin D has proved largely 
ineffective (13). This pattern is also observed for vitamin E, where biochemical measures of 
vitamin levels or reported vitamin intake have correlated with cognitive performance but 
vitamin supplementation as a potential treatment has had only mixed success in individuals 
with dementia (14, 15). In contrast, treatment with, or high recorded levels of, PUFAs appear 
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to have largely beneficial effects on cognition in individuals with dementia or at risk of 
dementia, particularly if combined with B vitamins (16).  
 
In the current study, we conducted an analysis of self-reported vitamin intake and vitamin 
biochemical measurements from two large middle-aged general population cohorts, the 
National Child Development Study (NCDS) 1958 birth cohort and the TwinsUK cohort. We 
focused on the relationship between vitamin intake and performance in mnemonic domains 
sensitive to the progression of dementia, thus aiming to provide a clinically sensitive measure 
of early cognitive decline.  
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Methods 
 
Study populations 
 
Access and ethical permission was granted by the UK Data Service and the TwinsUK 
Resource Executive Committee to obtain data including cognitive variables, biomedical 
measures and vitamin intake information by means of two longitudinal cohort studies, the 
NCDS 1958 and TwinsUK. As the individuals from both cohorts were surveyed multiple 
times over the years, the data from each cohort is associated with multiple age points.  
 
The NCDS 1958 is an ongoing longitudinal study of approximately 17,000 British 
individuals born within the same week in March 1958. This cohort includes comprehensive 
survey and assessment data for a wide range of variables, providing a rich resource for 
examining health across the lifespan. NCDS 1958 was approved by the UK Multi-Centre 
Research Ethics Committee. Data collection procedures for the NCDS surveys have been 
described elsewhere (17). Of the multiple surveys carried out in this cohort, we utilised data 
from the NCDS 1958 Sweep 8 taken from between 2008-2009 and the Biomedical Survey 
taken from between 2002-2004.  
 
The TwinsUK cohort is a repository of approximately 12,000 monozygotic and dizygotic 
British twins who have been serially assessed for health traits since 1992. Procedures used for 
sample and data collection have been described previously (18). TwinsUK was approved by 
the Guy’s and St Thomas’ Ethics Committee. Data for TwinsUK was requested and approved 
through the TwinsUK Resource Executive Committee based at the Department of Twins 
Research and Genetic Epidemiology at Kings College London.  
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Data processing 
 
In total, 9790 individuals were made available from the NCDS 1958 study and 1870 
individuals were made available from the TwinsUK study. The removal of missing data was 
then performed for each variables used in our analysis (supplementary Figure 1). A summary 
of variables and descriptive statistics for each cohort is presented in Table 1.  
 
In the NCDS 1958, self-reported questionnaire variables were obtained for daily use of single 
vitamins, combined vitamins, and folate intake. No further information was available from 
which to ascertain actual amounts of specific single or combined vitamins taken by cohort 
members. For our analysis, we derived a new vitamin intake variable from this data by 
categorising individuals as having ‘regular vitamin intake’ if they took single vitamins, 
combined vitamins, or folate more frequently than 3 times a week. We categorised 
individuals as having ‘irregular vitamin intake’ if they took single vitamins, combined 
vitamins, or folate less frequently than 2 times a week. Finally, we categorised individuals 
with no available data for single vitamins, combined vitamins, and folate as ‘non-reported 
vitamin intake’. We cannot say that these individuals categorically did not take vitamins, but 
that there was an absence of evidence regarding their vitamin intake. After data processing, 
4400 individuals from the NCDS 1958 cohort were categorised as belonging to these three 
vitamin intake groups (Figure 1).  
 
In the TwinsUK, self-reported questionnaire variables were obtained on whether people had 
taken vitamins every day for a month at the time of survey. For our analysis, we used this 
vitamin intake variable and categorised those who took vitamins every day for a month as 
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‘regular vitamin intake’. We categorised individuals who did not take vitamins every day for 
a month or individuals with no available data as ‘non-reported vitamin intake’. This left 1177 
individuals from the TwinsUK cohort (Figure 1). Further self-reported information describing 
specific vitamins intake was provided for some of the individuals in the questionnaire data. 
We assessed this data to ascertain whether individuals were taking any supplements that 
included B vitamins compared to other supplements that did not include B vitamins and 
derived a new variable classified as specific B vitamin intake.  
 
In addition to the survey questionnaire data, serum concentrations of homocysteine, vitamin 
B12, and folate were taken during biomedical visitations in the TwinsUK cohort. Previous 
cohort studies assessing Hcy levels and vitamin levels have grouped these variables as high 
or low in terms of their median values (5, 19). In keeping with these studies, we also grouped 
Hcy levels, vitamin B12 levels, and folate levels as high or low by median value. We also 
split these groups to define individuals with the highest Hcy or vitamin levels and individuals 
with the lowest Hcy or vitamin levels.  
 
Covariates 
 
Details of the NCDS 1958 demographic variables have been presented in detail in previous 
work whilst the impact of vitamin intake on cognitive performance has not (20). Variables 
such as ethnicity, socio-economic status, exercise, BMI, and further dietary details were not 
within the scope of our analysis.  However, sex and age were both included as covariates 
where appropriate. All TwinsUK members were female and so sex was not analysed in this 
cohort. In NCDS 1958, 2174 (49.5%) of the 4400 processed individuals were male and 2226 
(50.5%) were female. As the members of NCDS 1958 were all born within the same week in 
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1958 and hence they are all the same age, age was not analysed in this cohort. However, it 
should be emphasised that the NCDS 1958 cohort members were 45 years old when they 
provided self-reported vitamin intake data and 50 years old when they provided cognitive 
data. TwinsUK members were surveyed on multiple occasions for vitamin intake, vitamin 
levels, Hcy levels, and cognitive data over the course of the original study. These individuals 
were on average 49 years old (SD 10.8) when measured for vitamin levels, 57 years old (SD 
11.2) when measured for Hcy levels, 51 years old (SD 10.6) when cognitive testing was 
conducted, and 56 years old (11.5) when providing self-reported vitamin intake data. Due to 
the multiple age variables associated with this data, we used the variable with the most 
complete age information available from this cohort, namely the age at which Hcy 
measurements took place. This was used as a proxy variable for the effect of age in this 
cohort.  
 
Cognitive tests 
 
Cognitive test batteries were conducted during visitations in NCDS 1958 and TwinsUK 
studies with specific data from these batteries utilised in our analysis. In the NCDS 1958, 
Word Recall and Delayed Word Recall involved recalling a list of 10 words both 
immediately and after a delay at the end of the testing session. Animal Naming is a standard 
semantic fluency test where participants must name as many words as possible from a 
selected category. The category selected was animals.  The letter cancellation task is designed 
to measure attention and visual-spatial scanning abilities. Here, participants are required to 
scan a page of letters and the number of P’s & W’s they identify (accuracy) and the time 
taken to do so (speed) are recorded.   
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The TwinsUK cohort battery of tests included four Cambridge Neuropsychological Test 
Automated Battery (CANTAB) tasks; Delayed Matching to Sample (DMS), Paired 
Associates Learning (PAL), Pattern Recognition Memory (RPM) and Spatial Span (SSP). 
The CANTAB battery has been widely used in psychological testing and has been noted for 
its sensitivity to age related cognitive change (21).  The Delayed Matching to Sample task 
assesses visuospatial memory by presenting a pattern to participants, followed by a delay, 
before asking participants to identify the pattern from a selection of four. Pattern Recognition 
Memory presents a series of abstract visual patterns to participants before asking the 
participants to identify a pattern they had seen as well as a novel pattern they had not seen. 
Paired Associates Learning also assesses visuospatial memory by displaying “boxes” on the 
screen that conceal one or more patterns. After having seen beneath each “box” on the screen, 
a pattern is presented in the centre of the screen and participants must identify which “box” 
concealed the pattern. Spatial Span is a memory task in which a series of boxes change colour 
and participants are asked to recall the specific order of colours that appeared. Cognitive test 
output measures used were Paired Associates Learning Total Errors score, Delayed Matching 
to Sample Total Correct score and latency, Pattern Recognition Memory Total Correct score 
and latency, and Spatial Span Length score. In total, cognitive test data was available for 
4400 individuals in NCDS 1958 and 196 or 204 individuals in TwinsUK for vitamin 
supplement intake or vitamin serum levels, respectively.  
 
Statistical analysis 
 
Principal Component Analysis (PCA) is a transformative procedure used to identify the major 
sources of variance within a select number of variables. PCA was applied to cognitive test 
performance scores generated separately in the NCDS 1958 cohort and TwinsUK cohort 
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using Varimax rotation. The output values were measured with the Kaiser-Meyer-Olkin 
(KMO) measure of sampling adequacy and the Bartlett’s test of sphericity.  Retaining 
components with an eigenvalue > 1, were taken to indicate a single underlying factor. This 
resulted in the identification of three PCA derived factors reflective of verbal semantic 
memory (NCDS 1958) visuospatial associative memory (TwinsUK), and visual scanning 
(both cohorts) as detailed in supplementary Figure 2.  
 
Normal distribution of all available data was assessed using the Kolmogorov-Smirnov and 
Shapiro-Wilk normality tests. Logarithmic transformation was subsequently applied to 
variables which were not normally distributed and geometric means presented in these cases. 
One-way ANOVAs were performed to assess simple associations between vitamin intake or 
vitamin levels and cognitive performance. Cohen’s d was used to estimate effect sizes for 
these associations. For analyses incorporating the influence of Hcy in addition to vitamin 
intake or vitamin levels, as well as taking into account the covariate effects of age and sex, 
univariate linear models with post-hoc correction for multiple comparisons were applied. All 
analyses were two-tailed and a p-value < 0.05 was considered statistically significant. 
Statistical analysis was principally carried out using SPSS Statistics version 22.0 and R 
version 3.2.3.  
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Results 
 
Measurement of dementia-sensitive cognitive domains 
 
To evaluate cognitive performance relevant to the progression of dementia, we applied a 
dimensionality-reduction technique, PCA, to identify the major sources of variance within the 
cognitive tests from the NCDS 1958 cohort and the TwinsUK cohort. This led to the 
emergence of four derived cognitive factors which we construe to reflect 3 classes of 
cognitive processing. The first PCA model identified in the NCDS 1958 cohort included 
Word Recall (0.874), Delayed Word Recall (0.874), and Animal Naming (0.543), and had an 
eigenvalue of 1.55 accounting for 30.98% of the variance. As the main components assess 
verbal and semantic memory processing, we named this derived factor, verbal semantic 
memory. The second PCA model identified in the TwinsUK included Delayed Matching to 
Sample (0.738), Pattern Recognition Memory (0.714), Paired Associates Learning (-0.685), 
and Spatial Span (0.671), and had an eigenvalue of 2.38 accounting for 26.50% of the 
variance. The relationship between measures were in the expected directions, i.e. higher 
correct scores and lower number of errors made. As the components evaluate visual spatial 
relationships and recall of visual objects and patterns, we interpreted this factor to reflect 
‘visuospatial associative memory’.  
 
The third PCA factor identified in the NCDS 1958 cohort was comprised of the two letter 
cancellation outcome measures (P’s & W’s Scanned (0.956) and P’s & W’s Identified (0.948) 
and had an eigenvalue of 2.14 accounting for 42.78% of the variance. The fourth PCA model, 
was generated from the TwinsUK data an included latency scores for Delayed Matching to 
Sample (0.869) and Pattern Recognition Memory (0.714) and had an eigenvalue of 1.39 
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accounting for 15.41% of the variance.  Both the third and fourth factor we interpret as 
reflecting one form of cognitive processing, ‘visual scanning’ (Figure 1). Correlation 
coefficients support the relationship between these derived cognitive factors and their 
constituent cognitive tests (values presented in supplementary Figure 2). 
 
Two of these derived cognitive factors, visuospatial associative memory and verbal semantic 
memory, have previously been associated with sensitivity to dementia progression. 
Visuospatial associative memory tests have been highlighted in predicting progression from 
questionable dementia to AD as well as for classifying individuals with MCI (22). Verbal 
semantic tests have also been used to predict progression to AD as well as distinguishing 
between amnestic and non-amnestic diagnoses of MCI (23). In contrast, visual scanning is a 
more fundamental measure of general attention, providing a useful comparison to the 
dementia-sensitive factors (24).  
 
Influence of vitamins on cognitive performance 
 
Using these dementia-sensitive derived cognitive factors, we assessed self-reported vitamin 
intake and cognitive performance in the NCDS 1958 and TwinsUK general population 
cohorts. In the NCDS cohort, self-reported regular vitamin intake was associated with 
significantly better performance on both verbal semantic memory (regular intake = 0.23 
versus non-reported = -0.06, F = 26.932, p < 0.001, d = 0.29) and visual scanning (regular 
intake = 0.09 versus non-reported = -0.02, F = 4.314, p = 0.01, d = 0.12). Females performed 
better than males in both verbal semantic memory (p = 0.014) and visual scanning (p = 
0.003), irrespective of vitamin intake. In the TwinsUK cohort, self-reported regular vitamin 
intake was associated with significantly better performance on visuospatial associative 
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memory (regular intake = 0.14 versus non-reported = -0.44, F = 15.454, p < 0.001, d = 0.61) 
(Figure 2A). Moreover, individuals who specifically reported taking B vitamins showed 
better visuospatial associative memory performance compared to those who took other 
vitamins (B vitamins = 0.37 versus other vitamins = -0.02, F = 5.170, p = 0.025, d = 0.42). 
No influence of vitamin intake was observed for visual scanning (regular intake = -0.03 
versus non-reported = 0.001, F = 0.060, p = 0.8, d = 0.03).  
 
Assessment of serum concentrations of vitamin B12 and folate in TwinsUK showed no 
association with visuospatial associative performance (high vitamin B12 or folate = -0.16 
versus low vitamin B12 & folate = 0.11, F = 1.221, p = 0.120, d = 0.17), contrasting with the 
self-reported regular vitamin supplement findings in these cohorts. Age was found to be 
significantly associated with cognitive performance in TwinsUK, but did not influence the 
aforementioned relationships between vitamin supplement intake and visuospatial associative 
memory (p < 0.001) or visual scanning (p = 0.723) performance.  
 
Interactive influence of vitamins and homocysteine on cognitive performance  
 
Previous published findings have identified Hcy as a major risk factor for dementia and MCI 
(7, 19). Measurements of Hcy were unfortunately not taken in the NCDS 1958 cohort. 
However, both self-reported regular vitamin intake (regular intake = 12.07 µmol/L versus 
non-reported = 11.08 µmol/L, F = 19.905, p < 0.001, d = 0.27) and high serum levels of 
vitamin B12 and folate (high vitamin B12 & folate = 11.48 µmol/L versus low vitamin B12 
& folate = 10.17 µmol/L, F = 6.364, p = 0.001, d = 0.31) were associated with significantly 
lower levels of Hcy in TwinsUK (Figure 2B).  
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Interestingly, an interaction was found between Hcy levels and serum vitamin levels, and, 
visuospatial associative memory performance, where individuals with the highest levels of 
Hcy and high vitamin B12 levels performed significantly better than those with low vitamin 
B12 levels (p = 0.032) (Figure 2C). Moreover, the addition of age as a covariate increased the 
statistical significance of this finding (p < 0.001). As predicted, individuals with low vitamin 
B12 levels and lower Hcy performed better than those with low vitamin B12 levels and high 
Hcy, but this difference did not reach statistical significance (p = 0.110). No such interaction 
was seen for the visual scanning factor suggesting that the observed relationship between Hcy 
and B vitamins is specifically relevant to dementia-sensitive cognitive performance.  
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Discussion 
 
Using well collated survey and biomedical datasets from the NCDS 1958 and TwinsUK 
general population cohorts, our analysis revealed evidence of a positive association between 
self-reported regular vitamin intake and cognitive performance that was particularly 
significant in the dementia-sensitive visuospatial associative and verbal semantic memory 
factors. Moreover, we found that individuals with the highest levels of Hcy and high levels of 
B vitamins showed better visuospatial associative memory performance than those with low 
levels of B vitamins. These findings suggest that cognitive domains sensitive to dementia 
progression can be assessed in general population cohorts before the clinical onset of 
cognitive decline seen in MCI, and that performance in these domains can be altered through 
regular vitamin intake.  
 
The mnemonic benefits associated with middle-age vitamin intake in this study imply early 
protection against cognitive impairment, long before the age where vitamin intervention 
treatments are commonly studied in randomised control trials. B vitamin intake particularly 
follows a non-linear trajectory, as high levels of folate in elderly individuals have been 
associated with cognitive decline whilst moderate levels of supplementation resulted in health 
benefits (25). This supports the suggestion that moderate B vitamin use in middle-age could 
boost cognitive reserve before encountering age-associated cognitive risk (8). A similar 
argument has also been put forward with regards to cognitive enhancing nootropic drugs (26).  
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The use of cohort studies comes with inherent strengths and limitations. Variables are 
commonly collected during a number of surveys and hence obtained at different time points. 
However, whilst we acknowledge that this was the case for the NCDS 1958 and TwinsUK 
cohorts, this has not impeded the study of cognition using longitudinal cohort data (27). 
 
As with previous work exploring the relationship between vitamins and cognition, some 
incongruence between the qualitative measure of self-reported vitamin intake and the 
quantitative measure of serum vitamin levels was evident in our analyses. Specifically, self-
reported supplement intake showed significant associations with cognitive performance 
whereas vitamin levels did not. However, deeper analysis of B vitamin levels coupled with 
Hcy levels confirmed a positive association with cognitive function. This alludes to a 
mechanism of action via B vitamins and Hcy, either through excitotoxicity, impeded neural 
circuitry, or perturbed molecular pathways (28). Indeed, disturbance of the one-carbon cycle - 
which metabolises Hcy and requires B vitamins - could influence cognitive function via 
disrupted methyl donation for DNA, histone, and non-histone protein methylation pathways.  
 
It is possible that self-reported vitamin intake data, rather than highlighting a causal 
relationship between vitamin use and cognition, acts instead as a proxy for other 
environmental factors. As further nutritional and lifestyle information was not available from 
either NCDS 1958 or TwinsUK, we can only speculate as to any possible underlying 
relationships. For example, individuals who report taking vitamin supplements may be more 
health-conscious and more likely to exercise regularly, behaviour that is generally agreed to 
benefit cognition. Simply taking supplements could also have a placebo effect, as reported in 
previous vitamin trials (29). Whilst studies of multivitamin supplementation have had varied 
results (30), the qualitative self-reporting data analysed in this study demonstrates that 
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multivitamin intake as opposed to any single vitamin is most likely to benefit cognitive 
function. However, further randomised controlled trials assessing single and multivitamin 
supplementation will be needed to reach a firm conclusion surrounding vitamin intake and 
cognitive function. 
 
As the focus of dementia research shifts from treatment options to intervention strategies, 
individuals in middle-age who are asymptomatic for cognitive decline will become the targets 
for boosting cognitive reserve. The sensitivity of visuospatial associative and verbal semantic 
memory to early changes in cognition should prove valuable for both academic and 
therapeutic work in dementia prevention. The importance of regular vitamin intake 
highlighted in this study suggests that supplementation should be advocated in healthy 
middle-aged individuals, particularly those with elevated Hcy levels who are at higher risk of 
developing dementia. With credible pharmacological treatments for dementia currently 
beyond the horizon, vitamin supplementation may provide a practical and economically 
viable alternative in the effort to prevent dementia-related cognitive decline.  
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Figure legends 
 
Figure 1. Flow chart illustrating the processing of cognitive test performance and vitamin 
variables analysed for the NCDS 1958 and TwinsUK cohorts. Dementia sensitive cognitive 
factors were derived by PCA analysis of cognitive performance in the NCDS 1958 (verbal 
semantic memory factor) and the TwinsUK (visuospatial associative memory factor), and a 
general visual scanning derived factor identified for both cohorts. Self-reported vitamin 
intake information from both cohorts was used to derive a regular, irregular, or non-reported 
intake variables.  
 
Figure 2. Analysis of vitamin intake and vitamin and homocysteine (Hcy) levels and 
association with cognitive performance in the NCDS 1958 and TwinsUK cohorts.  
A. Regular (green) versus irregular (yellow) or non-reported (red) vitamin intake is 
associated with improved verbal semantic memory and visual scanning performance in 
NCDS 1958, and improved visuospatial associative memory performance in TwinsUK 
cohort.  
B. Regular vitamin intake and high B vitamin levels are associated with a reduction in Hcy 
levels in TwinsUK cohort.  
C. Individuals with the highest levels of Hcy are most sensitive to vitamin B12 levels, 
showing better or poorer visuospatial associative memory performance for higher or lower 
vitamin levels respectively.  
The number of individuals in each group is provided for each data point. Error bars indicate 1 
standard error (* p < 0.05, ** p < 0.01, *** p < 0.001).  
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Table 1. Descriptive statistics and mean cognitive test performance of the NCDS 1958 and 
TwinsUK cohort variables. Information on vitamin intake, biochemical measurements 
cognitive data was taken from multiple time points in each cohort as explicated by the ages 
associated with each variable. No vitamin or homocysteine levels were available from NCDS 
1958.  Hcy, homocysteine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
 
 
 
Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
26 
 
 
 
 
Figure 2.  
 
 
 
 
 
 
 
 
 
 
27 
 
Variables NCDS 1958 TwinsUK 
 
Number 
 
4400 
 
1177 
Sex:   
 Male 2174 - 
 Female 2226 1177 
Age:   
 Vitamin intake 45 56 ± 11.5 
 Vitamin levels - 49 ± 10.8 
 Hcy levels - 57 ± 11.2 
 Cognitive tests 50 51 ± 10.6 
Vitamin intake:   
 Regular 732 755 
 Irregular 160 - 
 Non-reported 3508 422 
Vitamin levels:   
 Vitamin B12 (pmol/L) - 595.3 ± 286.4 
 Folate (nmol/L) - 12.7 ± 6.1 
Hcy levels (µmol/L) - 12 ± 4.1 
Cognitive tests   
 Word recall 6.6 ± 1.5 - 
 Delayed word recall 5.5 ± 1.8 - 
 Animal naming 22.5 ± 6.3 - 
 Ps & Ws scanning 25.9 ± 7.3 - 
 Ps & Ws identified 21.7 ± 5.9 - 
 Delayed matching to sample latency - 3686.5 ± 1199.1 
 Delayed matching to sample correct - 17.2 ± 1.8 
 Pattern recognition memory latency - 2176.3 ± 631.5 
 Pattern recognition memory correct - 20.9 ± 2.4 
 Paired associates learning errors - 20.3 ± 17.3 
 Spatial span length - 5.5 ± 1.1 
 
Table 1. 
